Publications
-
Deconstructing p53 transcriptional networks in tumor suppression.
Bieging KT,
Attardi LD.
Trends Cell Biol.
2012;
22
(2):
97-106
-
Measurement of Haemophilus influenzae type a capsular polysaccharide antibodies in cord blood sera.
Schmidt DS,
Bieging KT, Gomez-de-León P, Villaseñor-Sierra A, Inostroza J, Robbins JB, Schneerson R, Carlone GM, Romero-Steiner S.
Pediatr Infect Dis J.
2012;
31
(8):
876-8
-
A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma.
Bieging KT,
Fish K, Bondada S, Longnecker R.
Blood.
2011;
118
(26):
6849-59
-
Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A.
Bieging KT,
Swanson-Mungerson M, Amick AC, Longnecker R.
Cell Cycle.
2010;
9
(5):
901-8
-
Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.
Bieging KT,
Amick AC, Longnecker R.
Proc Natl Acad Sci U S A.
2009;
106
(42):
17945-50
-
A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.
Rabin SD,
Veesenmeyer JL, Bieging KT, Hauser AR.
Infect Immun.
2006;
74
(5):
2552-61
-
Fluorescent multivalent opsonophagocytic assay for measurement of functional antibodies to Streptococcus pneumoniae.
Bieging KT,
Rajam G, Holder P, Udoff R, Carlone GM, Romero-Steiner S.
Clin Diagn Lab Immunol.
2005;
12
(10):
1238-42
Help